Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study (Q30400508)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study |
scientific article |
Statements
1 reference
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study (English)
1 reference
Cem Gabay
1 reference
Claire-Anne Siegrist
1 reference
Michael Bel
1 reference
Christophe Combescure
1 reference
Camillo Ribi
1 reference
Sara Meier
1 reference
Klara Posfay-Barbe
1 reference
Stéphane Grillet
1 reference
Jörg D Seebach
1 reference
Laurent Kaiser
1 reference
Werner Wunderli
1 reference
Pierre-André Guerne
1 reference
H1N1 Study Group
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference